- Home>
- Specialties>
- Oncology and Hematology>
- Thrombosis
Search for Thrombosis in Oncology and Hematology
Physician-authored summaries on the latest research on thrombosis, editorials on thrombosis, and perspectives on thrombosis - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 98 results - Relevance
- Date
You searched for: thrombosis in Oncology and Hematology
-
The Factor V Leiden Paradox
- May 1, 2012
- David Green, MD, PhD
- Oncology and Hematology
Data from a systemic review suggest that pulmonary embolism and deep-vein thrombosis do not necessarily have the same etiology.- Reviewing:
- van Langevelde K et al., Blood 2012 Apr 10;:
-
Preventing Venous Thromboembolism in Neurosurgery
- March 13, 2012
- David Green, MD, PhD
- Oncology and Hematology
A calf-compression device significantly reduced VTE in patients undergoing neurosurgical procedures.- Reviewing:
- Sobieraj-Teague M et al., J Thromb Haemost 2012 Feb; 10:229.
-
Preventing Catheter Thrombosis During Percutaneous Coronary Interventions
- February 7, 2012
- David Green, MD, PhD
- Oncology and Hematology
Heparin was more effective than fondaparinux at inhibiting clotting induced by the contact activation pathway.- Reviewing:
- Yau JW et al., Blood 2011 Dec 15; 118:6667.
-
Thigh-Length vs. Below-Knee Compression Stockings
- January 31, 2012
- David Green, MD, PhD
- Oncology and Hematology
Prevention of postthrombotic syndrome was similar with both types of stockings in patients with venous thrombosis, but adverse effects were less common with below-knee stockings.- Reviewing:
- Prandoni P et al., Blood 2011 Dec 16;:
-
Residual Venous Obstruction Does Not Predict Recurrent VTE
- August 2, 2011
- David Green, MD, PhD
- Oncology and Hematology
Results of a prospective cohort study and a meta-analysis suggest that the idea of performing CUS to detect RVO should be abandoned.- Reviewing:
- Le Gal G et al., J Thromb Haemost 2011 Jun; 9:1126. Carrier M et al., J Thromb Haemost 2011 Jun; 9:1119.
-
Risk Factors for Thrombosis in Essential Thrombocythemia
- May 3, 2011
- David Green, MD, PhD
- Oncology and Hematology
Risk factors for arterial thrombosis included age >60, prior thrombosis, cardiovascular risk factors, elevated white blood cell count, and JAK2 mutation.- Reviewing:
- Carobbio A et al., Blood 2011 Apr 13;:
-
D-Dimer Testing in Patients with Venous Thrombosis
- November 30, 2010
- David Green, MD, PhD
- Oncology and Hematology
Data from two studies suggest that it is reasonable to measure D-dimer levels 2 to 3 weeks after a patient stops anticoagulation therapy.- Reviewing:
- Douketis J et al., Ann Intern Med 2010 Oct 19; 153:523. Latella J et al., J Thromb Haemost 2010 Oct; 8:2169.
-
Should Patients Be Treated for Low-Risk Essential Thrombocythemia?
- September 28, 2010
- David Green, MD, PhD
- Oncology and Hematology
Most asymptomatic patients with ET fared well without specific antiplatelet therapy.- Reviewing:
- Alvarez-Larrán A et al., Blood 2010 Aug 26; 116:1205.
-
Thrombosis and Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma
- July 6, 2010
- David Green, MD, PhD
- Oncology and Hematology
MGUS and MM patients might merit antithrombotic or antiplatelet prophylaxis.- Reviewing:
- Kristinsson SY et al., Blood 2010 Jun 17; 115:4991.
-
High Thyroxine Levels and Risk for Venous Thrombosis
- June 29, 2010
- David Green, MD, PhD
- Oncology and Hematology
Data from a case-control study suggest there might be a link.- Reviewing:
- van Zaane B et al., Blood 2010 Jun 3; 115:4344.
-
Superficial Venous Thrombosis
- April 20, 2010
- David Green, MD, PhD
- Oncology and Hematology
Treatment for this condition should be considered, given the potential risks for more-serious thrombotic events.- Reviewing:
- Decousus H et al., Ann Intern Med 2010 Feb 16; 152:218.
-
Thrombosis Associated with Primary Myelofibrosis
- April 6, 2010
- David Green, MD, PhD
- Oncology and Hematology
Thrombotic events in patients with PMF occur at rates comparable to those in patients with essential thrombocythemia.- Reviewing:
- Barbui T et al., Blood 2010 Jan 28; 115:778.
-
Platelet Counts and Venous Thromboembolism in Cancer Patients
- March 23, 2010
- David Green, MD, PhD
- Oncology and Hematology
Higher risk for venous thrombosis correlated with higher platelet counts but not thrombopoietin levels.- Reviewing:
- Simanek R et al., J Thromb Haemost 2010 Jan; 8:114.
-
Polypectomy and Anticoagulant Therapy
- February 2, 2010
- David Green, MD, PhD
- Oncology and Hematology
Use caution when resuming anticoagulants after procedures.- Reviewing:
- Witt DM et al., J Thromb Haemost 2009 Dec; 7:1982.
-
Screening for Thrombophilia
- June 30, 2009
- David Green, MD, PhD
- Oncology and Hematology
Study results suggest that immediate relatives of patients with specific thrombophilic defects be considered for testing.- Reviewing:
- Lijfering WM et al., Blood 2009 May 21; 113:5314.
-
Optimal Duration of Anticoagulation for Venous Thromboembolism
- May 19, 2009
- David Green, MD, PhD
- Oncology and Hematology
Using ultrasonography data to guide duration of therapy helped lower rates of recurrent VTE.- Reviewing:
- Prandoni P et al., Ann Intern Med 2009 May 5; 150:577.
-
Statins and Venous Thrombosis
- April 14, 2009
- David Green, MD, PhD
- Oncology and Hematology
Recent studies confirm that statins lower risk for VT and suggest that the agents could aid in managing venous disease.- Reviewing:
- Ramcharan AS et al., J Thromb Haemost 2009 Apr; 7:514. Sørensen HT et al., J Thromb Haemost 2009 Apr; 7:521. Cushman M., J Thromb Haemost 2009 Apr; 7:511.
-
Postthrombotic Syndrome After Acute Deep Venous Thrombosis
- December 9, 2008
- David Green, MD, PhD
- Oncology and Hematology
Severe PTS was relatively uncommon in patients who received standard anticoagulation therapy.- Reviewing:
- Kahn SR et al., Ann Intern Med 2008 Nov 18; 149:698.
-
Predicting Venous Thromboembolism in Cancer Patients
- November 18, 2008
- David Green, MD, PhD
- Oncology and Hematology
Patients with VTE had higher levels of soluble platelet selectin than did those without VTE.- Reviewing:
- Ay C et al., Blood 2008 Oct 1; 112:2703.
-
Oral Treatment for Deep Venous Thrombosis
- October 21, 2008
- David Green, MD, PhD
- Oncology and Hematology
In a phase II trial, rivaroxaban was as effective and as safe as low-molecular-weight heparin.- Reviewing:
- Buller HR et al., Blood 2008 Sep 15; 112:2242.
Sort by:
Items 1 to 20 of 98 results - Relevance
- Date
